Clinical features, outcome and survival from cerebral toxoplasmosis in Edinburgh AIDS patients

International Journal of STD and AIDS

Volumn 7, Issue 4, 1996, Pages 258-264

  Laing, R B S ^a   Flegg, P J ^a   Brettle, R P ^a   Leen, C L S ^a   Burns, S M ^a  

^a CITY HOSPITAL   (United Kingdom)

Author keywords

Cerebral toxoplasmosis; Clinical features; Postmortem; Seroprevalence; Survival

Indexed keywords

ATOVAQUONE; AZITHROMYCIN; CD4 ANTIGEN; CLINDAMYCIN; COTRIMOXAZOLE; DAPSONE; PYRIMETHAMINE; SULFADIAZINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BRAIN INFECTION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; HUMAN; IMMUNE DEFICIENCY; NAUSEA; NEUTROPENIA; PREVALENCE; PRIORITY JOURNAL; RASH; SURVIVAL; TOXOPLASMOSIS; TREATMENT OUTCOME;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; ANTIFUNGAL AGENTS; ATOVAQUONE; AUTOPSY; AZITHROMYCIN; BRAIN; CD4 LYMPHOCYTE COUNT; CLINDAMYCIN; DRUG THERAPY, COMBINATION; FEMALE; GREAT BRITAIN; HUMANS; INCIDENCE; LYMPHOMA, AIDS-RELATED; MALE; MIDDLE AGED; NAPHTHOQUINONES; PYRIMETHAMINE; RETROSPECTIVE STUDIES; SULFADIAZINE; TOXOPLASMOSIS, CEREBRAL;

EID: 0029834537     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/0956462961917933     Document Type: Article

References (17)

1. Luft BJ, Remington JS. AIDS commentary: toxoplasmic encephalitis. J Infect Dis 1988;157:1-6
2. Israelski DM, Danneman BR, Remington JS. Toxoplasmosis in Patients with AIDS. The Medical Management of AIDS (2nd Edn.) Sande MA, Volberding PA (Eds). Philadelphia: WB Saunders, 1990
3. Pohle HD, Eichenlaub D. Toxoplasmosis of the CNS in AIDS patients. Symposium on HIV and the nervous system, Berlin. February 1987
4. Elder GA, Sever JL. Neurologic disorders associated with AIDS retroviral infection. Rev Infect Dis 1988;10:286
5. Porter SB, Sande MA. Toxoplasmosis of the central nervous system in the acquired immunodeficiency syndrome. N Engl J Med 1992;327(23):1643-8
6. Grant IH, Gold JWM, Rosenblum M, Niedzwiecki D, Armstrong D. Toxoplasma gondii serology in HIV-infected patients: the development of central nervous system toxoplasmosis in AIDS. AIDS 1990;4:519-21
7. Carr A, Tindall B, Brew BJ, Marriott DJ, Harkness JL, Penny R, Cooper DA. Low dose trimethoprim sulphamethoxazole prophylaxis for toxoplasmic encephalitis in patients with AIDS. Ann Intern Med 1992;117:106-11
8. Girard PM, Landman R, Gaudebout C, et al. Dapsonepyrimethamine compared with aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection. New Engl J Med 1993;328:1514-20
9. Ciricillo SF, Rosenblum ML. Imaging of solitary lesions in AIDS. J Neurosurg 1991;74:1029
10. Wanke C, Tuazon CU, Kovacs A, et al. Toxoplasma encephalitis in patients with acquired immune deficiency syndrome: diagnosis and response to therapy. Am J Trop Med Hyg 1987;36:509-16
11. Leport C, Raffi F, Matheron S. Treatment of central nervous system toxoplasmosis with pyrimethamine/sulphadiazine combinations in 35 patients with the acquired immune deficiency syndrome: efficacy of long-term continuous therapy. Am J Med 1988;84:94-100
12. Luft BJ, Hafner R, Korzun AH, et al. Toxoplasmic encephalitis in patients with the acquired immunodeficiency syndrome. N Engl J Med 1993;329:995-1000
13. Giampalmo A, Pesce C, Ardoino S, Provaggi MA, Quaglia AC. Neuropathological findings in an autopsy series of Italian subjects with AIDS. Clin Neuropathol 1989;8:120-5
14. Bolao F, Podzamczer D, Mascaro J, Miro JM, Sirera G, Cosin J, Gudiol F. Toxoplasmosis in Spanish AIDS patients. A multicenter study of prognostic factors and survival. Int Conf AIDS 1991;7(2) Jun 16-21 PG 252 (abstract no WB 2281)
15. Moore RD, Chaisson R, McArthur J. Natural history of central nervous system toxoplasmosis. Int Conf AIDS 1992;8 (2): July 19-24 PG B124 (abstract no PoB 3224)
16. Bolao F, Podzamczer D, Miro JM, Sirera G, Cosin J, Gudiol F. Toxoplasmosis in Spanish AIDS patients. A multicenter retrospective study. Int Conf AIDS 1990;6(1): Jun 20-23 PG 240 (abstract no Th B 473)
17. Haverkos HW and the Toxoplasma encephalitis study group. Assessment of therapy for toxoplasma encephalitis. Am J Med. 1987;82:907-14